NGAL Antibodies

Santa Cruz Biotechnology features a diverse variety of NGAL Antibodies for research focused on understanding Neutrophil Gelatinase-Associated Lipocalin (NGAL) in various biological processes. NGAL Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NGAL plays a vital role in the innate immune response and significantly contributes to iron transport and inflammation regulation. Research has shown NGAL's involvement in multiple pathological conditions, including acute kidney injury and cancer, establishing its importance as a biomarker for disease diagnosis and prognosis. Investigating NGAL functions continues to reveal potential therapeutic targets and disease mechanisms. Current studies highlight NGAL's significance in cellular defense mechanisms and tissue repair processes. Ongoing research demonstrates NGAL's crucial role in maintaining cellular homeostasis and responding to environmental stressors. Understanding NGAL's molecular interactions provides valuable insights into disease progression and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for NGAL research support scientists worldwide in advancing our understanding of human health and disease mechanisms.